Press Releases

Nov 13, 2021

Veracyte Announces New Data on Immuno-Oncology Offerings Presented at SITC 2021

Read More

Nov 09, 2021

Veracyte Announces Third Quarter 2021 Financial Results

Read More

Nov 05, 2021

Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia

Read More

Nov 03, 2021

New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis

Read More

Nov 02, 2021

Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company’s Immuno-Oncology Capabilities

Read More

Oct 26, 2021

New Data Demonstrate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier in Tailoring Treatment for Prostate Cancer Patients Experiencing Progression After Surgery

Read More

Oct 25, 2021

Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer

Read More

Oct 14, 2021

New Data to be Presented at ASTRO 2021 Further Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier

Read More

Oct 13, 2021

New Publication Demonstrates Ability of Veracyte’s Decipher Bladder Test to Identify Tumors Most Likely to Respond to Chemotherapy

Read More

Oct 12, 2021

Veracyte to Release Third Quarter 2021 Financial Results on November 9, 2021

Read More